









Markets
/
Stocks
/
nasdaq-atrc
/

AtriCure Inc

ATRC

28.880USD

-1.160-3.86%

Close 03/27, 16:00（ET）Quotes delayed by 15 min

476.09MMarket Cap

LossP/E TTM



AtriCure Inc

28.880

-1.160-3.86%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of AtriCure Inc

Currency: USD Updated: 2026-03-27

Key Insights

AtriCure Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 23 out of 208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 51.29.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

AtriCure Inc's Score

Industry at a Glance

Industry Ranking

23 / 208

Overall Ranking

102 / 4542

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Positive

AtriCure Inc Highlights

StrengthsRisks

AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 33.88% year-on-year.

Undervalued

The company’s latest PE is -120.46, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 49.59M shares, decreasing 0.21% quarter-over-quarter.

Held by CI Select Canadian Equity Fund

Star Investor CI Select Canadian Equity Fund holds 345.00 shares of this stock.

Analyst Rating

Based on 9 analysts

Buy

Current Rating

51.286

Target Price

+70.72%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-03-27

The current financial score of AtriCure Inc is 8.23, ranking 42 out of 208 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 140.50M, representing a year-over-year increase of 13.05%, while its net profit experienced a year-over-year increase of 111.28%.

Score

Industry at a Glance

Previous score

8.23

Change



Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

10.00

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

7.68

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

6.34

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.15

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

AtriCure Inc's Company Valuation

Currency: USD Updated: 2026-03-27

The current valuation score of AtriCure Inc is 7.17, ranking 116 out of 208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -120.46, which is -80.38% below the recent high of -23.63 and -14.16% above the recent low of -137.52.

Score

Industry at a Glance

Previous score

7.17

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 23/208

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-03-27

The current earnings forecast score of AtriCure Inc is 8.00, ranking 61 out of 208 in the Healthcare Equipment & Supplies industry. The average price target is 50.00, with a high of 64.00 and a low of 40.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 9 analysts

Buy

Current Rating

51.286

Target Price

+70.72%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

115

Total

Median

Average

Company name

Ratings

Analysts

AtriCure Inc

ATRC

Medtronic PLC

MDT

Stryker Corp

SYK

Zimmer Biomet Holdings Inc

ZBH

Abbott Laboratories

ABT

Dexcom Inc

DXCM

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-03-27

The current price momentum score of AtriCure Inc is 6.35, ranking 139 out of 208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 31.49 and the support level at 27.34, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.84

Change

-0.49

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(3)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

0.447

Neutral

RSI(14)

36.904

Neutral

STOCH(KDJ)(9,3,3)

33.881

Sell

ATR(14)

1.162

Low Volatility

CCI(14)

-63.942

Neutral

Williams %R

82.841

Oversold

TRIX(12,20)

-0.499

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

29.568

Sell

MA10

29.491

Sell

MA20

29.822

Sell

MA50

33.333

Sell

MA100

35.453

Sell

MA200

34.980

Sell

Institutional Confidence

Currency: USD Updated: 2026-03-27

The current institutional shareholding score of AtriCure Inc is 10.00, ranking 1 out of 208 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 116.79%, representing a quarter-over-quarter decrease of 2.07%. The largest institutional shareholder is The Vanguard, holding a total of 4.89M shares, representing 9.82% of shares outstanding, with 3.37% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

4.83M

-1.33%

Wellington Management Company, LLP

4.29M

+8.13%

AllianceBernstein L.P.

3.56M

-0.42%

BlackRock Institutional Trust Company, N.A.

3.41M

-1.00%

Hood River Capital Management LLC

3.05M

-0.51%

Nomura Investment Management Business Trust

2.29M

-8.54%

State Street Investment Management (US)

1.26M

-0.74%

Geode Capital Management, L.L.C.

1.19M

+0.79%

First Light Asset Management, LLC

890.36K

-12.29%

Champlain Investment Partners, LLC

1.98M

-1.91%

Risk Assessment

Currency: USD Updated: 2026-03-27

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of AtriCure Inc is 6.67, ranking 54 out of 208 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.42. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.